FDA streamlines its ‘compassionate use’ process

The possibility that an investigational drug, not yet approved for commercial use, could be life-saving to some patients has been an ongoing dilemma for industry and for healthcare providers (HCPs). On the one hand, desperate patients, sensing that such a […]

Read More